The Management of Hypertension in Pregnancy

Advances in Chronic Kidney Disease

Volumn 20, Issue 3, 2013, Pages 229-239

  Kattah, Andrea G ^a   Garovic, Vesna D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antihypertensive agents; Gestational hypertension; Hypertension; Preeclampsia; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ALISKIREN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; NITROPRUSSIDE SODIUM; PLACEBO; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLURRED VISION; BRAIN HEMORRHAGE; BRONCHOSPASM; CEREBRAL BLINDNESS; CHRONIC DISEASE; CONGENITAL MALFORMATION; CONTINUOUS INFUSION; DRUG SAFETY; ELECTROLYTE DISTURBANCE; EXERCISE TOLERANCE; FATIGUE; FORWARD HEART FAILURE; GLOMERULUS FILTRATION RATE; HEADACHE; HELLP SYNDROME; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY CORTEX NECROSIS; LIFESTYLE MODIFICATION; LUNG EDEMA; LUPUS LIKE SYNDROME; MATERNAL HYPERTENSION; OLIGURIA; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK ASSESSMENT; SCOTOMA; SEDATION; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SOLUTIO PLACENTAE; TERATOGENICITY;

ANTIHYPERTENSIVE AGENTS; DELIVERY, OBSTETRIC; ECLAMPSIA; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 84876858912     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2013.01.014     Document Type: Review

References (68)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183(1):S1-S22.
2. Berg C.J., Callaghan W.M., Syverson C., Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010, 116(6):1302-1309.
3. Ayala D.E., Hermida R.C. Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy. Chronobiol Int 2013, 30(1-2):233-259.
4. Hermida R.C., Ayala D.E., Mojon A., et al. Blood pressure excess for the early identification of gestational hypertension and preeclampsia. Hypertension 1998, 31(1):83-89.
5. Vollebregt K.C., Gisolf J., Guelen I., Boer K., van Montfrans G., Wolf H. Limited accuracy of the hyperbaric index, ambulatory blood pressure and sphygmomanometry measurements in predicting gestational hypertension and preeclampsia. J Hypertens 2010, 28(1):127-134.
6. Brown M.A., Bowyer L., McHugh L., Davis G.K., Mangos G.J., Jones M. Twenty-four-hour automated blood pressure monitoring as a predictor of preeclampsia. Am J Obstet Gynecol 2001, 185(3):618-622.
7. Bergel E., Carroli G., Althabe F. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database Syst Rev 2002, (2):CD001231.
8. Natarajan P., Shennan A.H., Penny J., Halligan A.W., de Swiet M., Anthony J. Comparison of auscultatory and oscillometric automated blood pressure monitors in the setting of preeclampsia. Am J Obstet Gynecol 1999, 181(5 Pt 1):1203-1210.
9. Lo C., Taylor R.S., Gamble G., McCowan L., North R.A. Use of automated home blood pressure monitoring in pregnancy: is it safe?. Am J Obstet Gynecol 2002, 187(5):1321-1328.
10. August P. Preeclampsia: new thoughts on an ancient problem. J Clin Hypertens (Greenwich) 2000, 2(2):115-123.
11. Sibai B.M., Anderson G.D. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 1986, 67(4):517-522.
12. Noraihan M.N., Sharda P., Jammal A.B. Report of 50 cases of eclampsia. J Obstet Gynaecol Res 2005, 31(4):302-309.
13. Altman D., Carroli G., Duley L., et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002, 359(9321):1877-1890.
14. Odendaal H.J., Pattinson R.C., Bam R., Grove D., Kotze T.J. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990, 76(6):1070-1075.
15. Sibai B.M., Mercer B.M., Schiff E., Friedman S.A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994, 171(3):818-822.
16. Churchill D., Duley L. Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database Syst Rev 2002, (3):CD003106.
17. Sibai B.M. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol 2011, 205(3):191-198.
18. Koopmans C.M., Bijlenga D., Groen H., et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009, 374(9694):979-988.
19. Bateman B.T., Shaw K.M., Kuklina E.V., Callaghan W.M., Seely E.W., Hernandez-Diaz S. Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One 2012, 7(4):e36171.
20. von Dadelszen P., Ornstein M.P., Bull S.B., Logan A.G., Koren G., Magee L.A. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000, 355(9198):87-92.
21. Rothberger S., Carr D., Brateng D., Hebert M., Easterling T.R. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens 2010, 23(11):1234-1240.
22. Abalos E., Duley L., Steyn D.W., Henderson-Smart D.J. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001, (2):CD002252.
23. Magee L.A., Helewa M., Moutquin J.M., von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008, 30(3 suppl):S1-S48.
24. Moser M., Brown C.M., Rose C.H., Garovic V.D. Hypertension in pregnancy: is it time for a new approach to treatment?. J Hypertens 2012, 30(6):1092-1100.
25. Ferrer R.L., Sibai B.M., Mulrow C.D., Chiquette E., Stevens K.R., Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 2000, 96(5 Pt 2):849-860.
26. Thorsteinsdottir B., Kane G.C., Hogan M.J., Watson W.J., Grande J.P., Garovic V.D. Adverse outcomes of renovascular hypertension during pregnancy. Nat Clin Pract Nephrol 2006, 2(11):651-656.
27. Smith C.M., Wigent P.J. Pheochromocytoma in pregnancy: considerations for the advanced practice nurse. J Perinat Neonatal Nurs 1998, 12(2):11-25.
28. Oliva R., Angelos P., Kaplan E., Bakris G. Pheochromocytoma in pregnancy: a case series and review. Hypertension 2010, 55(3):600-606.
29. Stowasser M., Ahmed A.H., Pimenta E., Taylor P.J., Gordon R.D. Factors affecting the aldosterone/renin ratio. Horm Metab Res 2012, 44(3):170-176.
30. Sibai B.M., Lindheimer M., Hauth J., et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998, 339(10):667-671.
31. van Rijn B.B., Hoeks L.B., Bots M.L., Franx A., Bruinse H.W. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006, 195(3):723-728.
32. Sibai B.M., Ramadan M.K., Usta I., Salama M., Mercer B.M., Friedman S.A. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993, 169(4):1000-1006.
33. Nwoko R., Plecas D., Garovic V.D. Acute kidney injury in the pregnant patient. Clin Nephrol 2012, 78(6):478-486.
34. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142(2):159-167.
35. Sibai B.M., Barton J.R. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 2007, 196(6):514.e1-514.e9.
36. ACOG technical bulletin. Hypertension in pregnancy. Number 219-January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996, 53(2):175-183.
37. Lindheimer M.D., Taler S.J., Cunningham F.G. ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich) 2009, 11(4):214-225.
38. Okanloma K.A., Moodley J. Neurological complications associated with the pre-eclampsia/eclampsia syndrome. Int J Gynaecol Obstet 2000, 71(3):223-225.
39. Sharshar T., Lamy C., Mas J.L. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995, 26(6):930-936.
40. Martin J.N., Thigpen B.D., Moore R.C., Rose C.H., Cushman J., May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005, 105(2):246-254.
41. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334(8):494-500.
42. Wagner S.J., Acquah L.A., Lindell E.P., et al. Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clin Proc 2011, 86(9):851-856.
43. Wilson B.J., Watson M.S., Prescott G.J., et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003, 326(7394):845.
44. Garovic V.D., Bailey K.R., Boerwinkle E., et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens 2010, 28(4):826-833.
45. Ray J.G., Vermeulen M.J., Schull M.J., Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366(9499):1797-1803.
46. Bar J., Kaplan B., Wittenberg C., et al. Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol Dial Transpl 1999, 14(5):1129-1132.
47. Vikse B.E., Irgens L.M., Leivestad T., Skjaerven R., Iversen B.M. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008, 359(8):800-809.
48. Artal R., O'Toole M. Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period. Br J Sports Med 2003, 37(1):6-12. discussion 12.
49. Falcao S., Bisotto S., Michel C., et al. Exercise training can attenuate preeclampsia-like features in an animal model. J Hypertens 2010, 28(12):2446-2453.
50. Saftlas A., Wang W., Risch H., Woolson R., Hsu C., Bracken M. Prepregnancy body mass index and gestational weight gain as risk factors for preeclampsia and transient hypertension. Ann Epidemiol 2000, 10(7):475.
51. Siega-Riz A.M., Viswanathan M., Moos M.K., et al. A systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: birthweight, fetal growth, and postpartum weight retention. Am J Obstet Gynecol 2009, 201(4):339.e1-339.e14.
52. Papiernik E., Kaminski M. Multifactorial study of the risk of prematurity at 32 weeks of gestation. I. A study of the frequency of 30 predictive characteristics. J Perinat Med 1974, 2(1):30-36.
53. Abenhaim H.A., Bujold E., Benjamin A., Kinch R.A. Evaluating the role of bedrest on the prevention of hypertensive diseases of pregnancy and growth restriction. Hypertens Pregnancy 2008, 27(2):197-205.
54. Cockburn J., Moar V.A., Ounsted M., Redman C.W. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982, 1(8273):647-649.
55. Sibai B.M., Mabie W.C., Shamsa F., Villar M.A., Anderson G.D. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990, 162(4):960-966. discussion 966-967.
56. Butters L., Kennedy S., Rubin P.C. Atenolol in essential hypertension during pregnancy. BMJ 1990, 301(6752):587-589.
57. Ismail A.A., Medhat I., Tawfic T.A., Kholeif A. Evaluation of calcium-antagonist (Nifedipine) in the treatment of pre-eclampsia. Int J Gynaecol Obstet 1993, 40(1):39-43.
58. Magee L.A., Schick B., Donnenfeld A.E., et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996, 174(3):823-828.
59. Gowda R.M., Khan I.A., Mehta N.J., Vasavada B.C., Sacchi T.J. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 2003, 88(2-3):129-133.
60. Khandelwal M., Kumanova M., Gaughan J.P., Reece E.A. Role of diltiazem in pregnant women with chronic renal disease. J Matern Fetal Neonatal Med 2002, 12(6):408-412.
61. Frishman W.H., Schlocker S.J., Awad K., Tejani N. Pathophysiology and medical management of systemic hypertension in pregnancy. Cardiol Rev 2005, 13(6):274-284.
62. Magee L.A., Cham C., Waterman E.J., Ohlsson A., von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003, 327(7421):955-960.
63. Cameron H.A., Ramsay L.E. The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J (Clin Res Ed) 1984, 289(6442):410-412.
64. Handler J. Hydralazine-induced lupus erythematosis. J Clin Hypertens (Greenwich) 2012, 14(2):133-136.
65. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006, 354(23):2443-2451.
66. Li D.K., Yang C., Andrade S., Tavares V., Ferber J.R. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 2011, 343:d5931.
67. Cabassi A., Rocco R., Berretta R., Regolisti G., Bacchi-Modena A. Eplerenone use in primary aldosteronism during pregnancy. Hypertension 2012, 59(2):e18-e19.
68. Mosca L., Benjamin E.J., Berra K., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011, 57(12):1404-1423.